Great job Atonewater

Ver

Come on man, can u think anything positive abt company

I sold mine too will wait for it to go lower and rebuy it . Real PoS

Dew be careful fcsc will be 3 $ soon than don't complain me I did no warned u. Gltu

I am not going to sell in short term. it is my long term holding with price target of 3 $s

I understand your feelings as i am in the same boat as you are. I gave my opinion , i am not saying that what i think is absolutely true.

Yes , you are right everything seems to be lined up but one thing, Financing. I think investors are waiting to hear about that from the company. It will wait and watch period till than.

Agree great stuff

Very good find Rickkk. Appreciate it sir!

Great presentation! four great things about presentation.

1. company is ready for more partnership.
2. 175 M $ intellectual properties
3. 12 year market exclusivity for wrinkles.
4. once they come to an agreement about acne scars with FDA( company is actively in contact with FDA about that), that will be huge for the company. GLTA

What did they said to you. Positive ... Negetive

Oh really dew we did not know that revenue comes from ophthalmology business.
We thought it comes from baby formula LOL.

Agree

Daddy , I am betting big coz pernonck has excellent background in marketing it is a huge asset . Companies r made by peoPle . Fcsc has it. People will look back. And think about it below 1 bucks. I think next week would be last chance to get in below 1. Good luck I am in for long term .

very good article already marketing in florida:


http://blog.plasticsurgeryinflorida.com/2011/07/new-wrinkle-treatment-approved-return.html

FDA Approves Cloning Skin Cells to Fight Wrinkles

http://www.cosmeticplatform.com/2011/07/fda-approves-cloning-skin-cells-to-fight-wrinkles.html
Link:
Posted by on July 2, 2011in Beauty News|0 Comment
¦Posted by Sharon on June 27, 2011 at 01:23PM

We’ve successfully cloned an entire sheep and five human embryos. Now, thanks to Fibrocell Science, Inc., we can get injections of our own cloned skin cells to fight wrinkles. What’s next? Adamantium-infused bones a la “Wolverine?”

•
While I’m all for extending youth and the tools that help get us there, the level of our cloning capabilities is, honestly, a bit scary. All those movie scenes and Sci-Fi novels depicting the human race dominated (and destroyed) by intelligent beings that we ourselves created come to mind?

•
But I digress.

•
Just last week, the FDA approved of a new type of injectable called laViv, a soft-tissue stimulator made from the actual tissue of the patient. No more silicone injections of foreign materials to achieve smooth, expression-less skin. Now, your very own skin cells will stimulate the production of collagen, which is responsible for your skin’s firmness. LaViv is “the first and only personalized cell-based aesthetic treatment,” says David Pernock, Chairman and CEO of Fibrocell Science, Inc.

•
This is how laViv works:

•
Your dermatologist or plastic surgeon numbs a small area behind your ear and removes three tiny pieces of skin, which are sent to a lab where they purify the cells and clone them into millions of new cells. After those cells cook for three months, they’re tested for sterility, frozen in small vials, and stored.

•
With a day’s notice, the vials can be defrosted and sent to your dermatologist’s office, where your doc can inject them the very next day. As for the results? These “couture” injectables last at least six months, with minimal side effects (swelling and bruising are the most common). And once you send in your skin cells, your supply of personalized injectables is limitless.

•
So far this technology is only approved to soften “moderate to severe nasolabial folds and wrinkles” — better known as your smile lines. But Pernock says that this is just the beginning of aesthetic cloning. •


He hopes to continue to advance the cloning technology to treat other areas of the face, the décolletage, and even acne and burn scars. With laViv entering the growing $1 billion annual market of aesthetic injectables, Pernock is confident his company’s new technology will change the game. “We think we’re going to compete effectively in the marketplace,” he says.

•
While I don’t mind getting injections of my own skin cells to banish my ghastly lines, I sure hope there doesn’t come a day when I’m walking down the street and run into my very own, personalized wrinkle-less clone.

FCSC: Autologous Fibroblast Injections for Nasolabial Fold Augmentation

The number of available injectable filler options has grown exponentially since the first non-collagen based products became available in 2002. Since then more than a dozen new variations of fillers has appeared, most of which are derivatives of hyaluron-based materials. All of these injectable materials have a limited duration of effectiveness because they are broken down and absorbed. The search for longer-lasting fillers is ongoing but has remained elusive to datge.



There is great appeal in using filler materials extracted from the patient as it is both natural and may last much longer or even be permanent. Such has been the widespread use of liposuction-harvest fat but that is not as convenient as a more off-the-shelf product. In that vein, a company called Fibrocell Science has just received FDA approval for an injectible wrinkle treatment that uses a patient’s own cells.



According to the company and its product name, LaVív, it is an aesthetic cell therapy for improving the appearance of moderate-to-severe nasolabial folds in adults. The treatment uses a patient’s own fibroblasts which are extracted from a punch biopsy behind the ear. It is then sent to Fibrocell’s laboratory where the patient’s fibroblasts are grown and eventually returned to the physician for injection into the patient. The theory is that these transplanted fibroblasts will produce new collagen which will then fill and plump out the nasolabial fold. The entire process from harvest to treatment time is about 50 days. The fibroblast cultures are stored at the company so repeat injection material can be obtained for future treatments.



The clinical study submitted to the FDA for this autologous injection therapy was based on treatment results from human nasolabial folds being injected in three sessions spaced about six weeks apart. The results showed that a significantly greater number of patients had reduced nasolabial folds when injected with laVív than with a placebo. The patients were evaluated out to six months after the treatments.



While the FDA approval for this technology is recent, it is a older technique that was initially introduced over a decade ago. At that time, it was offered as a physician-ordered treatment that did not have FDA-approved status. I did several patients at that time and was using it in the treatment of depressed facial scars, specifically acne scars. It was my understanding that the company eventually decided to seek FDA approval for fear that growing and storing human cells would eventually come under the scrutiny of the FDA. This is now the fruit of a long effort at going through the FDA submission process.



In seeking FDA approval, it was logical to conduct the study for this autologous injection in the treatment of nasolabial folds. This is because every synthetic injectable filler that is commercially available is based on the use of nasolabial folds. This represents the easiest path for a study submitted to the FDA to gain approval. It can only be marketed as such but physicians no doubt will apply it to many other facial areas and aesthetic needs as well.



Does these fibroblast injections work? Do they grow, produce collagen, and last permanently? Is it better long-term that investing in temporary synthetic injectable fillers? These are the questions that widespread clinical use will eventually answer.



Dr. Barry Eppley

www.eppleyplasticsurgery.com

Indianapolis Indiana

Deben, happy 4 th july to you too. i think the best thing from now is to ignore him . i agree! God Bless America!

You will be in excurciating pain in few days watching it RUN! get used to it!

Get used to the boredom. Now that FCSC got FDA approval, there are no major catalysts for longs to look forward to. By the company’s own admission, the commercial launch of laViv is going to be excruciatingly slow, and talk about lucrative partnerships is just a message-board pipe dream.

Fibrocell events:

Fibrocell Science, Inc. at The Collins Stewart Conference
Tuesday, August 9, 2011
New York City

Fibrocell Science, Inc. at The Oppenheimer 22nd Annual Healthcare Conference
Tuesday, December 13, and Wednesday, December 14 2011
New York City

they are silent , and i think they will open the mouth big time , once and when they open.

Firbocell in spanish media:



link:

http://www.elpais.com.uy/suplemento/ds/seis-sentidos/sds_575378_110626.html

Google translate:



New wrinkle treatment
The U.S. agency that regulates drugs and food approved the sale of the first aesthetic treatment cell for facial wrinkles, announced Wednesday Fibrocell Science, which developed this therapy. The treatment involves removing skin cells and cultured to multiply, before re-injected into wrinkles, and so attenuate them. In normal skin, cells produce collagen, fibrous proteins that give the tissues a mechanical resistance to stretching. AFP

Fibrocell in romania:

Link:
http://www.monitorulsv.ro/Sanatate/2011-06-24/Prima-terapie-celulara-contra-ridurilor-autorizata-in-SUA


Google translate:


U.S. medicines regulatory agency (Food and Drug Administration / FDA) approved the launch of the first customized cell therapy against wrinkles, announced Wednesday Fibrocell Science, the company that developed this therapy, informs AFP.

FDA representatives have authorized this treatment, called Viv (azficel-T) on Tuesday, says the company Fibrocell Science in a statement.

Viv is the first and also the only treatment approved by FDA aesthetic custom cell to reduce wrinkles in adults, particularly pronounced when a person smiles.

This treatment is the removal of skin cells, fibroblasts, and their cultivation in the laboratory so that they multiply, and then re-injected into wrinkles as to mitigate them.

In normal skin, fibroblasts produce collagen, the fibrous protein that provides a specific tissue mechanical strength to the tensile force.

In clinical trials organized, well-tolerated therapy patients Viv. Most side effects observed were the weak skin reactions, which disappeared in less than a week.

FDA authorized the marketing of the treatment, after reviewing the results of two Phase 3 clinical trials, conducted on a sample of 421 patients.

"Using patient cells that produce collagen, is a revolutionary tool in the treatment of nasolabial wrinkles, restoring fresh face," said Robert Weiss, associate professor at the faculty of medicine at Johns Hopkins University in the U.S. state of Maryland and Maryland Institute Director Laser Skin and Vein.

Robert Weiss is the researcher who led the clinical trials in which therapy was used Viv.

fibrocell in italian media.

Link: http://ilserpentedigaleno.blogosfere.it/2011/06/trattamento-estetico-o-intervento-terapeutico.html

Google translate:

It's called LaViv ( azficel-T ) and is the newest treatment cosmetic for wrinkles of Fibrocell Science .

No, I'm wrong! E 'is too simplistic to talk about aesthetic treatment : it is a real prorpio therapeutic intervention , the first ever U.S. FDA approved for wrinkles around the nose and face of adults.

In fact it's interventions customized through the ' removal behind the ear cells ( fibroblasts ) that produce collagen and, expanded in culture, are re-injected to smooth wrinkles .

The ' OK FDA has come after the results of two Phase III clinical trials conducted on 421 patients .

The treatment was administered in three sessions of about five weeks away.

Of course it will take additional studies to define the duration of treatment beyond 6 months, as well as the side effects that for the time you configure in redness at the injection site, echimosi, swelling, pain, bleeding, swelling, nodules, papules, irritation, dermatitis and itching.

Fibrocell set up a registry of approximately 2700 patients to further assess the safety of this autologous cell therapy.

The border aesthetics used increasingly to cell manipulation, but sometimes I think a wrinkle tells much more of a smooth face and is more of a face rejuvenated personalizing the Dorian Gray. But that's another story .... and science also has its own way.

yes, i was surprised to see exposure in china, europe, russia . Pernock is quitely doing his stuff. great for long term share holders.

fibroocell menrtioned in nederland media( again used google translate)


New treatments for wrinkles in U.S.
WASHINGTON - The United States has approved a new treatment for wrinkles. This manufacturer has Fibrocell Science Wednesday. The Food and Drug Administration, the agency in the U.S. quality and safety of many consumer checks, agrees to the agent laViv.
It follows its own skin cells used to eliminate wrinkles. The cosmetics company is using collagen fibers, for the firmness of the skin, for them to multiply and there was a substance of it. Then the substance is injected to fill wrinkles. By many factors such as sunlight, diet, smoking and age shrink collagen in the skin cells. The result is that the elasticity of the skin which reduces wrinkles. .

ORiginal is below:

Nieuwe behandelingen tegen rimpels in VS
WASHINGTON - In de Verenigde Staten is toestemming gegeven voor een nieuwe behandeling tegen rimpels. Dat heeft fabrikant Fibrocell Science woensdag laten weten. De Food and Drug Administration, het agentschap dat in de VS de kwaliteit en veiligheid van veel consumentenproducten controleert, is akkoord met het middel laViv.
Daarbij worden eigen huidcellen gebruikt om rimpels weg te werken. Het cosmeticabedrijf gebruikt collageencellen, die voor de stevigheid van de huid zorgen, om ze te vermeerderen en er een substantie van te maken. Vervolgens wordt de substantie geïnjecteerd om de rimpels op te vullen. Door allerlei factoren zoals zonnestralen, voeding, roken en ouderdom krimpen collageencellen in de huid. Het gevolg hiervan is dat de elasticiteit van huid vermindert waardoor rimpels ontstaan. .

Fibrocell in chinese media , google translate in great.

June 22, 2011, Fibrocell Science Corporation announced that the U.S. Food and Drug Administration (FDA) has approved laViv (azficel-T) for the improvement of adults with moderate to severe nasolabial wrinkles (smile lines) beautifully. laViv individual aesthetic is a cell therapy, and its patented technology to extract the patient's own skin cells produce collagen - and the proliferation of fibroblasts.


Before you start laViv treatment, patients start to extract ear fibroblast samples sent Fibrocell Science Laboratory. After about 90 days, to train hundreds of millions of fibroblast cells, and then be stored frozen for later use. laViv by injection applications, the recommended course of treatment, including three consecutive times, the adjacent two treatments at intervals of 3 to 6 weeks.

FDA approval laViv a certain extent, is based on two three, multi-center, randomized, double-blind, placebo-controlled study results, the subjects of 421 patients. Treatment in three phases, the adjacent phase interval of 5 weeks. According to the evaluation of researchers and patients, using strict composite primary endpoint. The results showed that, laViv effective treatment group showed that the treatment was significantly greater than the proportion of patients with placebo. In trials in patients receiving Laviv 3rd and after the last treatment period of 6 months follow-up appearance of always improving nasolabial fold wrinkles.

6 months after the expected duration of the effect is the subject of further study. In order to meet the requirements of a listing, Fibrocell will create about 2,700 patients were included in a registration office in order to further evaluate autologous cell therapy safety.

In clinical trials, the most common adverse reactions are injection site redness, bruising, swelling, pain, bleeding, edema, nodules, papules, stimulation, dermatitis and itching. The severity of injection site reactions in the majority of mild to moderate and subside within 1 week. ( Bio Valley Bioon.com)









Share | Favorites



Top

0




Step

0




Comment



Valley Friends Comments



No comments yet. Comments, you will first appear here.




???? ????
Anonymous comments will appear after you log on here my comments (available after login) registered my comment
Comments for Google users to express their views do not agree with the view that biological Valley or confirm the description





Related News

FDA approval Nulojix for kidney transplantation to prevent acute rejection
FDA: Chinese pharmaceutical four to six thousand poor manufacturing practices Liu Cheng
corn to produce collagen for human safer
German hospital "nurse robot" first appeared in
the Israeli R & D Embedded bionic electronic retina
iPhoneECG: self-test ECG with the iPhone
FDA asked Pfizer to carry out Oxecta listing abuse / misuse of
FDA: icatibant effective in the treatment of hereditary angioedema
Glenmark's generic FDA-approved contraceptives in the United States Listed
FDA issued nine new tobacco warning labels












Latest News


Hottest news


Recommended News























Top
Taobao Mall online sale of drugs involved: five medical B2C settled
Li and Gates joined together to launch tobacco control
E. coli outbreak in Germany to determine the culprit for the bean sprouts
Pharmaceutical Factory of Harbin Pharmaceutical Group, the sewage is so willfully suspend or reduce




































Focus






Figure
Dialogue

Comment
People & Company






Quick Links




Recruitment / Executive Search







New Jobs bio-industry


Shanghai, Beijing and Guangzhou biotechnology-related industries on the latest job information, all in biological recruitment.















Figure

The secret of success








Recruitment

Widen the road for your career








Related reports

Dongsheng innovative access to finance








Classifieds







Molecular Biology Products




Quantitative PCR
Eppendorf fluorescence quantitative
PCR instrument






Real-time PCR instrument
ABI StepOne TM real-time PCR instrument, the latest software, user-friendly, simple operation






PCR products were purified
A variety of manufacturers and all kinds of PCR product purification kit







Quantitative PCR reagents
The most complete quantitative PCR reagents







RT-PCR full-service program
From the primer design to test full-service






Search more related products






















You are here: Bio Valley > Biopharmaceutical Industry > Industry News > Biotech News > Text
Contact Us
Back to top



Trend
Biological research
Advances in bio-industry
Advances in biomedical
People & Company
Blog comments
Service

http://www.google.com/hostednews/afp/article/ALeqM5h51yPsN7eScu5phNxV6ErQyN73uA?docId=CNG.156f4e7c349525b4f9b52b846b6ded5f.671

fibrocell in portugese

fibrocell mentioned in russian media:



http://kp.ua/daily/250611/287393/


Google translate:

And for that, do not have to use the miracle drugs. Medicine are simple: take a small amount of patient fibroblasts (connective tissue cells, creating conditions for their reproduction in the laboratory. And after about three months, when their number will suffice - a few million, the fibroblasts are injected into the area of ??skin covered with wrinkles. As a result, the skin is smoothed. This is because that fibroblasts are responsible for synthesis in the body of the extracellular collagen skeleton of the skin. In addition, fibroblasts support the livelihoods of not only the connective tissue and other cells - they provide nutrients.

Studies on 421 volunteer confirmed the safety of the drug and its effectiveness in removing wrinkles nasolabial folds.

Cell preparation laViv, developed by U.S. company Fibrocell Science has already been registered by the Office of the Food and Drug Administration (FDA), reported AFP. Feature means that it is manufactured by a particular consumer from his own cells.

fibrocell in chinese media:

http://www.afpbb.com/article/environment-science-it/science-technology/2809220/7440168


Google translate:

U.S. authorities approved a new beauty treatment the wrinkles in the injection drug using cells produce collagen in his skin - AFP - 29 6. Food and Drug Administration ( FDA ) last week, Pennsylvania ( Pennsylvania ) County biotechnology company Fibrocell Science 's new beauty therapy " Laviv "authorized the. The company "fibroblast" cells of the skin extracts that produce collagen, called a patent for the process have to be cultured. Sent to a laboratory cell samples taken from patients undergoing surgery of the ear, if you can replicate the results of hundreds of millions of fibroblasts, and stored frozen until needed for treatment. Process until you can say about 90 days duplication. "Eliminate wrinkles around the nose and mouth, the idea of using a collagen cells to the patient will regain the youthful revolutionary wrinkle treatment among the" one and tested it, Johns Hopkins Medicine ( Johns Hopkins University School of Medicine ) A · Robert Weiss ( Robert A. Weiss ) said said. "Because biological processes, it can provide an apparent natural treatments over time," it. According to the company, reddish areas or injected as a side effect, there can be swelling and bruising, a majority of adverse events in clinical trials is minor, were resolved within a week. Persists about the extent to which the treatment effect that we need further investigation. Have been studied so far is only to say the second half of the annual injection. (C) AFP

fibrocell mentioned:

http://www.savings.com/blog/post/Fibrocell-Science-Skin-Cell-Cloning-and-Other-Costly-Anti-Aging-Procedures.html

LOL! you know there is fair chances that botox may be removed.

Dew you r living in different world and if u think this stock is POS than why in the world you waste your time to come on this board, definitely some evil interest

good post buddy, i dont think we all should look at day to day price fluctuation. it will be easily 2 plus stock IMO in few months. hang on everybody, dont panic, dont let MMs rip you off, we will get reward.

fcsc - with u

good info thx

No explanation dew, you will know it in few weeks, LOL!

Dew, just wait for few weeks and you will be in same situation as cryptic was after AMRN, 140% run, LOL, he was jumping even more than you , and suddenly he stopped writing any posts, poor guys, LOL!

FCSC: DADDY ME TOO. LONG TERM IS THE WAY TO GO. FORGET ABOUT SHORT TERM FLUCTUATION , I CAN SMELL, IT WILL BE A TEN BAGGER IN TRUE SENSE.